Literature DB >> 1378498

The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma.

N Y Haboubi1, P Clark, S M Kaftan, P F Schofield.   

Abstract

The prognosis of colorectal carcinoma relies heavily on pathological staging which includes the metastatic state of lymph nodes. Colorectal resectates from 47 patients (41 with colorectal carcinoma and six with non-malignant disease) were entered into a study to assess the best method for detecting metastases in lymph nodes. The maximum number of lymph nodes was harvested at an initial careful examination of the specimen. Subsequently, the pericolic and perirectal fat was dissected out, dehydrated in alcohol, cleared in xylene and further lymph nodes were recovered. Both sets of lymph nodes were examined by the standard histological method and subsequently stained immunohistochemically for cytokeratins (CK). The mean number of lymph nodes recovered at the initial dissection from all 47 cases was 6.7, this was raised to 58.2 after xylene clearance, ie an average of 51.5 lymph nodes were not recovered by traditional methods. At the initial dissection no epithelial cells were detected in any of the lymph nodes from the nonmalignant cases or 25 of the malignant cases. In the other 16 cases, epithelial cells were detected by H&E in 38 lymph nodes. Thus the initial staging was 3 Dukes A, 22 Dukes B and 16 Dukes C. After immunohistochemistry, eight additional cases (originally staged Dukes B) showed epithelial cells in the lymph nodes, these were chiefly occult invasion, raising the involved lymph nodes number to 70. After xylene clearance and applying the CK staining, an additional 135 lymph nodes were found to be involved, thus the overall number of involved lymph nodes was increased to 205. The combined technique changed the Dukes staging in 12 out of 41 cases of colorectal carcinoma, resulting finally in 3 Dukes A, 10 Dukes B and 28 Dukes C, ie 55% of Dukes B become Dukes C.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378498      PMCID: PMC1293543     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  7 in total

1.  Current concepts in cancer. Nodal clearance and detection.

Authors:  J W Pickren
Journal:  JAMA       Date:  1975-03-03       Impact factor: 56.272

2.  Discussion on major surgery in carcinoma of the rectum with or without colostomy, excluding the anal canal and including the rectosigmoid: general results of surgical treatment.

Authors:  C E DUKES
Journal:  Proc R Soc Med       Date:  1957-12

3.  Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques.

Authors:  J L Mansi; U Berger; P Wilson; R Shearer; R C Coombes
Journal:  J Urol       Date:  1988-03       Impact factor: 7.450

4.  The prognostic value of the modifications of the Dukes' C class of colorectal cancer. An analysis of the NSABP clinical trials.

Authors:  N Wolmark; B Fisher; H S Wieand
Journal:  Ann Surg       Date:  1986-02       Impact factor: 12.969

5.  Metastases in small lymph nodes from colon cancer.

Authors:  L Herrera-Ornelas; J Justiniano; N Castillo; N J Petrelli; J P Stulc; A Mittelman
Journal:  Arch Surg       Date:  1987-11

6.  Clearance technique for the detection of lymph nodes in colorectal cancer.

Authors:  S J Cawthorn; N M Gibbs; C G Marks
Journal:  Br J Surg       Date:  1986-01       Impact factor: 6.939

7.  The spread of rectal cancer and its effect on prognosis.

Authors:  C E DUKES; H J BUSSEY
Journal:  Br J Cancer       Date:  1958-09       Impact factor: 7.640

  7 in total
  26 in total

Review 1.  The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment.

Authors:  Jeremy R Parfitt; David K Driman
Journal:  J Clin Pathol       Date:  2006-10-17       Impact factor: 3.411

2.  Intraoperative diagnosis of lymph node metastasis by transcription-reverse transcription concerted reaction assay in gastric cancer.

Authors:  Ryouichi Hirayama; Akiyoshi Seshimo; Kunitomo Miyake; Masako Nishizawa; Shingo Kameoka
Journal:  Int J Clin Oncol       Date:  2013-06-14       Impact factor: 3.402

3.  Effect on lymph node status of triple levelling and immunohistochemistry with CAM 5.2 on node negative colorectal carcinomas.

Authors:  A G Nicholson; C G Marks; M G Cook
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

Review 4.  High ligation of the inferior mesenteric artery in rectal cancer surgery.

Authors:  Jin-Ichi Hida; Kiyotaka Okuno
Journal:  Surg Today       Date:  2012-10-07       Impact factor: 2.549

5.  More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study.

Authors:  Steven L Chen; Anton J Bilchik
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

6.  Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy.

Authors:  Rodrigo Oliva Perez; Angelita Habr-Gama; Sidney Tomyo Nishida Arazawa; Viviane Rawet; Sheila Aparecida Coelho Siqueira; Desidério Roberto Kiss; Joaquim José Gama-Rodrigues
Journal:  Int J Colorectal Dis       Date:  2005-03-10       Impact factor: 2.571

7.  [Acetone compression. A fast, standardized method to investigate gastrointestinal lymph nodes].

Authors:  O Basten; D Bandorski; C Bismarck; K Neumann; A Fisseler-Eckhoff
Journal:  Pathologe       Date:  2010-05       Impact factor: 1.011

8.  The pathologist's role in rectal cancer patient assessments.

Authors:  Joseph E Willis
Journal:  Clin Colon Rectal Surg       Date:  2007-08

9.  Multicentre review of lymph node harvest in colorectal cancer: are we understaging colorectal cancer patients?

Authors:  P J Mitchell; S Ravi; B Grifftiths; F Reid; D Speake; C Midgley; N Mapstone
Journal:  Int J Colorectal Dis       Date:  2009-04-23       Impact factor: 2.571

10.  [Lymph node preparation in colorectal cancer. Ex vivo methylene blue injection as a novel technique to improve lymph node visualization].

Authors:  B Märkl; T Kerwel; H Jähnig; M Anthuber; H Arnholdt
Journal:  Pathologe       Date:  2008-07       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.